Takotsubo Cardiomyopathy and 5-Fluorouracil: Getting to the Heart of the Matter
Takotsubo cardiomyopathy is a rare but increasingly recognized phenomenon, which can occur as a side-effect of chemotherapeutic agents, in particular, the antimetabolite 5-fluorouracil. We describe a case of delayed Takotsubo cardiomyopathy after 3 weeks of adjuvant 5-fluorouracil for resected recta...
Saved in:
| Main Authors: | Stephanie Hui-Su Lim, Sharon Mary Wilson, Arnagretta Hunter, Jane Hill, Philip Beale |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Case Reports in Oncological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2013/206765 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RATIONAL PHARMACOTHERAPY IN TAKOTSUBO CARDIOMYOPATHY
by: S. Marchev, et al.
Published: (2015-12-01) -
Application of T1 MRI in takotsubo cardiomyopathy
by: Liene Balode, et al.
Published: (2025-07-01) -
Takotsubo Cardiomyopathy “Variations on a Theme”
by: Kjell Bogaard, et al.
Published: (2011-01-01) -
Takotsubo Cardiomyopathy Associated with Polycythemia Vera
by: Sijan Basnet, et al.
Published: (2018-01-01) -
Takotsubo Cardiomyopathy: A New Perspective in Asthma
by: Fady Y. Marmoush, et al.
Published: (2015-01-01)